Search results
20 maj 2021 · This review will discuss the role of key imaging modalities, correlate imaging signs across varied STGD1 presentations and illustrate the use of multimodal imaging as an outcome measure in determining the efficacy of emerging STGD1 specific therapies.
1 gru 2014 · Imaging Characteristics. Fluorescein angiography (FA), fundus autofluorescence (FAF), and spectral-domain optical coherence tomography (SD-OCT) can help diagnose and characterize Stargardt disease. The hallmark finding on imaging of Stargardt disease is a “dark choroid” on FA (Fig. 2).
6 mar 2023 · To explore fundus autofluorescence (FAF) imaging as an alternative to electroretinography as a noninvasive, quick, and readily interpretable method to predict disease progression in Stargardt disease (STGD).
8 sty 2024 · Interpret the various imaging modalities used to diagnose and assess Stargardt disease. Collaborate with interprofessional team members to provide efficient, comprehensive, and coordinated care for patients with Stugardt disease.
21 sie 2017 · Two types of AOSLO imaging exist, confocal and split-detector (SD, non-confocal). Confocal imaging requires an intact photoreceptor outer segment, and dark spaces represent cellular vs. outer segment loss.
26 lip 2024 · Advancements in multimodal imaging and functional testing, including adaptive optics-based scanning laser ophthalmoscopy and microperimetry, will be crucial in establishing whether transplanted cells directly improve visual function in specific retinal areas.
Stargardt macular dystrophy (Stargardt disease; STGD1; OMIM 248200) is the most prevalent inherited macular dystrophy. STGD1 is an autosomal recessive disorder caused by multiple pathogenic sequence variants in the large ABCA4 gene (OMIM 601691).
